Apoptosis induced m mammalian cells by small peptides that functionally antagonize the rb-regulated e2f transcription factor

Nature Biotechnology

Volumn 15, Issue 9, 1997, Pages 896-901

  Bandara, Lasantha R ^a   Girling, Rowena ^b   La Thangue, Nicholas B ^a,c  

^a Prolifix Ltd 1 3 Burtonhole Lane ^*  (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

Apoptosis; E2F antagonist; Peptide therapeutics; Tumor suppressor

Indexed keywords

DNA BINDING PROTEIN; TRANSCRIPTION FACTOR E2F;

APOPTOSIS; ARTICLE; BINDING AFFINITY; CANCER CELL; DNA BINDING; HUMAN; HUMAN CELL; MAMMAL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; CARRIER PROTEINS; CELL CYCLE PROTEINS; DIMERIZATION; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; HUMANS; MAMMALS; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PEPTIDES; PROMOTER REGIONS (GENETICS); PROTEIN BIOSYNTHESIS; TRANSCRIPTION FACTOR DP1; TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED;

MAMMALIA;

EID: 0030828488     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt0997-896     Document Type: Article

References (37)

1. Weinberg, R.A. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323-330.
2. Nevins, J.R. 1992. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science 258:424-429.
3. La Thangue, N.B. 1994. DRTF1/E2F:an expanding family of heterodimeric transcription factors implicated in cell-cycle control. Trends Biochem. Sci. 19:108-114.
4. Lam, E.W.-F. and La Thangue, N.B. 1994. DP and E2F proteins: coordinating transcription with cell cycle progression. Curr. Op. Cell. Biol. 6:859-866.
5. Johnson, D.G., Schwarz, J.K., Cress, W.D., and Nevins, J.R. 1993. Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature 365:349-351.
6. Qin X.-Q., Livingston, D.M., Kaelin, W.G. and Adams, P.D. 1994. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc. Natl. Acad. Sci. USA 91:10918-10922.
7. Wu, X. and Levine, A.J. 1994. P53 and E2F-1 cooperate to mediate apoptosis. Proc. Natl. Acad. Sci. USA 91:3602-3606.
8. Zhu, L., Van den Heuvel, S., Helin, K., Fattaey, A., Ewen, M., Livingston, D., et al. 1993. Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. Genes Dev. 7:1111-1125.
9. Sherr, C.J. 1993. Mammalian G1 cyclins. Cell 73:1059-1065.
10. Pines, J. 1995. Cyclins, CDKs and cancer. Sem. Cancer Biol. 6:63-72.
11. Kato, J., Matsushime, H., Hiebert, S.W., Ewen, M.E., and Sheer, C.J. 1993. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinases CDK4. Genes Dev. 7:331-342.
12. Sherr, C.J. and Roberts, J.M. 1995. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9:1149-1163.
13. Lukas, J., Parry, D., Aagaard, L, Mann, D.J., Bartkova, J., Strauss, M., et al. 1995. Retinoblastoma-protein-dependent cell-cycle inhibition by the tumor suppressor p16. Nature 375:503-506.
14. Koh, J., Enders, G.H., Dynlacht, B.D. and Harlow, E. 1995. Tumor-derived p16 alleles encoding proteins defective in cell-cycle inhibition. Nature 375:506-510.
15. Bandara, L.R. and La Thangue, N.B. 1991. Adenovirus Eia prevents the retinoblastoma gene product from complexing with a cellular transcription factor. Nature 351:494-497.
16. Chellappan, S.R, Hiebert, S., Mudryj, M., Horowitz, J.M., and Nevins, J.R. 1991. The E2F transcription factor is a cellular target for the Rb protein. Cell 65:1053-1061.
17. Zwicker, J. and Müller, R. 1997. Cell-cycle regulation of gene expression by transcriptional repression. Trends.Gen. 13:3-6.
18. Zwicker, J., Lucibello, F.C., Wolfraim, L.A., Gross, C., Truss, M., Engeland, K., Müller, R. 1995. Cell-cycle regulation of the cyclin A, cdc25C and cdc2 genes is based on a common mechanism of transcriptional repression. EMBO J. 14:4514-4522.
19. Flemington, E.K., Speck, S.H and Kaelin, W.G. Jr. 1993 E2F-1 mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product. Proc. Natl. Acad. Sci. USA 90:6914-6918.
20. Helin, K., Harlow, E., Fattaey, A.R. 1993. Inhibition of E2F-1 trans-activation by direct binding of the retinoblastoma protein. Mol. Cell. Biol. 13:6501-6508.
21. Girling, R., Partridge, J.F., Bandara, LR., Burden, N., Totty, N.F., Hsuan, J.J. and La Thangue, N.B. 1993. A new component of the transcription factor DRTF1/E2F. Nature 362:83-87.
22. Bandara, L.R., Buck, V.M., Zamanian, M., Johnston, L.H., and La Thangue, N.B. 1993. Functional synergy between DP-1 and E2F-1 in the cell cycle-regulating transcription factor DRTF1/E2F. EMBO J. 13:4317-4324.
23. Bandara, L.R., Lam, E.W.-F., Sorensen, T.S., Zamanian, M., Girling, R., and La Thangue, N.B. 1994. DP-1: a cell cycle-regulated and phosphorylated component of transcription factor DRTF1/E2F which is functionally important for recognition by pRb and the adenovirus E4 orf 6/7 protein. EMBO J. 13:3104-3114.
24. Johnson, D.G., Cress, W.D., Jakoi, L, and Nevins, J.R. 1994. Oncogenic capacity of the E2F1 gene. Proc. Natl. Acad. Sci. USA 91:12823-12827.
25. Singh, P., Wong, S.H., and Hong, W. 1994. Overexpression of E2F-1 In rat embryo fibroblasts leads to neoplastic transformation. EMBO J. 14:3329-3338.
26. Jooss, K., Lam, E.W.-F., Bybee, A., Girling, R., Müller, R., and La Thangue, N.B. 1995. Proto-oncogenic properties of the DP family of proteins. Oncogene 10:1529-1536.
27. Xu, F.H., Alphey, L., Bandara, L.R., Lam, E.W.-F., Glover, D., and La Thangue, N.B. 1995. Functional conservation of the cell cycle-regulating transcription factor DRTF1/E2F and Its pathway of control in Drosophila melanogaster. J. Cell Science 108:2945-2954.
28. Derossi D., Joliot A.H., Chassaing G., and Prochlantz A. 1994 The third helix of the antennapedia homeodomain translocates through biological membrances. J. Biol. Chem. 269:10444-10450.
29. CDKN2/INK4A Current Biology 6:84-91.
30. Beljersbergen, R.L., Kerkhoven, R.M., Zhu, L., Carlee, L., Voorhoeve, P.M., and Bernards, R. 1994. E2F-4, a new member of the E2F gene family, has oncogenic activity and associates with p 107 in vivo. Genes Dev. 8:2680-2690.
31. Pan, H. and Griggs, A.E. 1994. Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: Implication for tumor suppressor gene function in development. Genes Dev. 8:1285-1299.
32. Clarke, A.R., Mazndag, E.R., Van Roon, M., Van der Lugt, N.M.T., Van der Valk, M., Hooper, M.J., et al. 1992. Requirement for a functional Rb-1 gene in murine development. Nature 359:328-330.
33. Jacks, T, Fazell, A., Schmitt, E.M., Branson, R.T., Goodell, M.A., and Weinberg, R.A. 1992. Effects of an Rb mutation in the mouse. Nature 359:295-300.
34. Morgenbesser, S.D., Williams, B.O., Jacks, T., and DePinho, R.A. 1994. P53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens. Nature 371:72-74.
35. Field, S.J., Tsal, F-Y., Kuo, F., Zubiaga, A.M., Kaelin, W.G., Livingston, D.M., et al. 1996. E2F-1 functions in mice to promote apoptosis and suppress proliferation cell. Cell 85:549-561.
36. Yamasaki, L, Jacks, T., Branson, R., Goillot, E., Harlow, E. and Dyson, N. 1996. Tumor induction and tissue a trophy in mice lacking E2F-1. Cell 85:537-5478.
37. Weintraub, S.J., Cho, K.N.B., Luo, R.X., Zhang, S.H., He, S., and Dean, D.C. 1995. Mechanism of active transcriptional repression by the retinoblastoma protein. Nature 358:259-261.